CROSSMODAL DIVIDED ATTENTION IN RATS - EFFECTS OF CHLORDIAZEPOXIDE AND SCOPOLAMINE

被引:60
作者
MCGAUGHY, J [1 ]
TURCHI, J [1 ]
SARTER, M [1 ]
机构
[1] OHIO STATE UNIV, DEPT PSYCHOL, COLUMBUS, OH 43210 USA
关键词
DIVIDED ATTENTION; SCOPOLAMINE; CHLORDIAZEPOXIDE; RAT;
D O I
10.1007/BF02244774
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
''Divided attention'' is a psychological construct that hinges on assumptions about a fixed finite capacity of subjects to simultaneously process multiple sets of information. A model of a crossmodal divided attention task was developed in rats. Initially, rats were trained consecutively in operant auditory and visual conditional discrimination tasks. The final task consisted of two successive blocks of 20 trials per modality (modality certainty), followed by 60 trials comprising a semi-randomized sequence of stimuli of both modalities (auditory or visual) and qualities (flashing/pulsing or constantly turned on; modality uncertainty). In comparison to unimodal blocks of trials, performance in the mixed condition was assumed to reflect the demands on the parallel processing of two sets of stimulus-response rules. While response accuracy remained unchanged, response latencies were generally longer in the bimodal condition. Administration of scopolamine (0.03, 0.06, 0.1 mg/kg) or chlordiazepoxide (1, 3, 5, 8 mg/kg) dose-dependently increased response latencies. The scopolamine-induced increase in response latencies was greater in the mixed condition. Cost-benefit analyses demonstrated that the absolute divided attention costs (in ms) were generally higher for visual than for auditory stimuli. Both drugs produced qualitatively similar effects; however, scopolamine was more potent in increasing the absolute divided attention costs than chlordiazepoxide. These data are discussed in terms of the validity of this animal paradigm, and of hypotheses about the effects of benzodiazepine receptor agonists and muscarinic antagonists on brain information processing capacity.
引用
收藏
页码:213 / 220
页数:8
相关论文
共 38 条
[1]  
Allport D. A., 1989, FDN COGNITIVE SCI, P631
[2]   EFFECTS OF CHOLINERGIC AND NONCHOLINERGIC DRUGS ON VISUAL-DISCRIMINATION AND DELAYED VISUAL-DISCRIMINATION PERFORMANCE IN RATS [J].
ANDREWS, JS ;
GRUTZNER, M ;
STEPHENS, DN .
PSYCHOPHARMACOLOGY, 1992, 106 (04) :523-530
[3]   Working memory [J].
Baddeley, Alan .
CURRENT BIOLOGY, 2010, 20 (04) :R136-R140
[4]  
Craik F.I.M., 1982, AGING COGNITIVE PROC, P191, DOI DOI 10.1007/978-1-4684-4178-9_11
[5]  
CURRAN HV, 1991, PSYCHOPHARMACOLOGY, V105, P1
[6]  
CURRAN HV, 1991, PSYCHOPHARMACOLOGY, V103, P83
[7]  
CURRAN HV, 1991, P FABRE MON, V4, P395
[8]   DISSOCIATION BETWEEN THE EFFECTS OF BENZODIAZEPINE RECEPTOR AGONISTS ON BEHAVIORAL VIGILANCE AND RESPONSIVITY [J].
DUDCHENKO, P ;
PAUL, B ;
SARTER, M .
PSYCHOPHARMACOLOGY, 1992, 109 (1-2) :203-211
[9]   FAILURE OF A CHLORDIAZEPOXIDE TO REPRODUCE THE BEHAVIORAL-EFFECTS OF MUSCIMOL ADMINISTERED INTO THE BASAL FOREBRAIN [J].
DUDCHENKO, P ;
SARTER, M .
BEHAVIOURAL BRAIN RESEARCH, 1992, 47 (02) :202-205
[10]   GABAERGIC CONTROL OF BASAL FOREBRAIN CHOLINERGIC NEURONS AND MEMORY [J].
DUDCHENKO, P ;
SARTER, M .
BEHAVIOURAL BRAIN RESEARCH, 1991, 42 (01) :33-41